Literature DB >> 9113278

Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon.

C S Lieber1, M A Leo, S I Aleynik, M K Aleynik, L M DeCarli.   

Abstract

Diets supplemented with polyunsaturated fatty acids or triglycerides exacerbate alcohol-induced liver injury in rats, whereas, in baboons, polyenylphosphatidylcholine (PPC) protects against alcohol-induced fibrosis and cirrhosis. Because the aggravation in rats was attributed to enhanced lipid peroxidation, the present study was undertaken to assess parameters of oxidative stress in percutaneous liver biopsies of baboons fed alcohol, with or without PPC (2.8 g per 1000 calories). F2-isoprostanes and 4-hydroxynonenal, breakdown products of lipid peroxidation, were determined by gas chromatography/mass spectrometry, and alpha-tocopherol was measured by HPLC with electrochemical detection. Hepatic 4-hydroxynonenal was significantly increased in animals fed alcohol, but this was fully prevented by PPC. F2-isoprostanes were also significantly lower after PPC and ethanol than after ethanol alone, and the alcohol-induced glutathione decrease was attenuated. All of these parameters were normal in the animals withdrawn from alcohol, even with persistence of significant liver disease. Because peroxidation products are fibrogenic, their decrease could contribute to the antifibrogenic property of the phospholipids. In conclusion, PPC significantly attenuates ethanol-induced oxidative stress, which may explain, at least in part, its protective effect against alcoholic liver injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113278

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  17 in total

1.  Alcoholic Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

Review 2.  Pathophysiological basis for antioxidant therapy in chronic liver disease.

Authors:  Jesús Medina; Ricardo Moreno-Otero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

Authors:  I A Leclercq; G C Farrell; J Field; D R Bell; F J Gonzalez; G R Robertson
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Reactive oxygen species and NADPH oxidase 4 induced by transforming growth factor β1 are the therapeutic targets of polyenylphosphatidylcholine in the suppression of human hepatic stellate cell activation.

Authors:  Remina Ikeda; Kyoko Ishii; Yoshiko Hoshikawa; Junya Azumi; Yuta Arakaki; Toshihiro Yasui; Shizuka Matsuura; Yoshiaki Matsumi; Yohei Kono; Yusuke Mizuta; Akihiro Kurimasa; Ichiro Hisatome; Scott L Friedman; Hironaka Kawasaki; Goshi Shiota
Journal:  Inflamm Res       Date:  2011-02-13       Impact factor: 4.575

5.  TLR-2-mediated metabolic reprogramming participates in polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization.

Authors:  Ting-Ting Feng; Xiao-Ying Yang; Shan-Shan Hao; Fen-Fen Sun; Ye Huang; Qi-Si Lin; Wei Pan
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

Review 6.  New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments.

Authors:  Charles S Lieber
Journal:  Curr Gastroenterol Rep       Date:  2004-02

7.  Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Nils U Olsson; Norman Salem
Journal:  J Hepatol       Date:  2008-06-04       Impact factor: 25.083

8.  Systemic phosphatidylcholine pretreatment protects canine esophageal mucosa during acute experimental biliary reflux.

Authors:  Gabor Eros; Jozsef Kaszaki; Miklos Czobel; Mihaly Boros
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

9.  Perturbations in polar lipids, starvation survival and reproduction following exposure to unsaturated fatty acids or environmental toxicants in Daphnia magna.

Authors:  Namrata Sengupta; Patrick D Gerard; William S Baldwin
Journal:  Chemosphere       Date:  2015-11-21       Impact factor: 7.086

10.  Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis.

Authors:  Gabor Eros; Saleh Ibrahim; Nikolai Siebert; Mihály Boros; Brigitte Vollmar
Journal:  Arthritis Res Ther       Date:  2009-03-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.